Literature DB >> 6449011

Syngeneic tumor cells can induce alloreactive T killer cells: a biological role for transplantation antigens.

V Schirrmacher, D Hübsch, F Garrido.   

Abstract

A chemically induced sarcoma of BALB/c (H-2d) mice, MCG4, is shown to induce in BALB/c lymphocytes a primary anti-tumor cytolytic T lymphocyte (CTL) reaction in vitro. The anti-tumor CTL showed tumor specificity but reacted also with normal cells expressing distinct H-2 alloantigens. The CTL response could be shown to be induced by and directed against alloantigenic determinants expressed on two different molecules, one H-2Kk-like the other H-2Dk-like. The biological significance of these findings is discussed with regard to (i) possibility of derepression of normally silent H-2 genes in tumor cells and normal cells, (ii) generation of alloreactivity in ontogeny, and (iii) role of alloreactive T cells in eliminating cells expressing wrong gH-2 antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449011      PMCID: PMC350068          DOI: 10.1073/pnas.77.9.5409

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

Review 2.  Immune surveillance directed against depressed cellular and viral alloantigens.

Authors:  W J Martin
Journal:  Cell Immunol       Date:  1975-01       Impact factor: 4.868

3.  H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection.

Authors:  F Garrido; V Schirrmacher; H Festenstein
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

4.  Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines.

Authors:  F Garrido; H Festenstein; V Schirrmacher
Journal:  Nature       Date:  1976-06-24       Impact factor: 49.962

5.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

6.  New genetic model for allelism at histocompatibility and other complex loci: polymorphism for control of gene expression.

Authors:  W F Bodmer
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

Review 7.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

8.  Changes in HL-A antigen profiles on SV40-transformed human fibroblasts.

Authors:  M A Pellegrino; S Ferrone; C Brautbar; L Hayflick
Journal:  Exp Cell Res       Date:  1976-02       Impact factor: 3.905

9.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.

Authors:  V Schirrmacher; K Bosslet; G Shantz; K Clauer; D Hübsch
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

10.  Lung tumor-associated derepressed alloantigen coded for by the K region of the H-2 major histocompatibility complex.

Authors:  T G Gipson; M Imamura; M A Conliffe; W J Martin
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  4 in total

1.  Unexpected H-2 antigen expression by mouse tumor cells, a cautionary note.

Authors:  P J Robinson; K Sege; P Altevogt; P A Peterson; L Lundin; F Garrido; V Schirrmacher
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  Spontaneous autocytotoxicity against an unexpected H-2d haplotype in MRL/lpr (H-2k) autoimmune disease-prone mice.

Authors:  P Bobé; G Gachelin; N Kiger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells.

Authors:  Alejandro Pando; John L Reagan; Martha Nevola; Loren D Fast
Journal:  Exp Hematol Oncol       Date:  2018-10-04

4.  Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response.

Authors:  Alejandro Pando; Loren Fast; Patrycja M Dubielecka; Anna Chorzalska; Sicheng Wen; John Reagan
Journal:  J Blood Med       Date:  2021-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.